Clinical Trials Logo

Clinical Trial Summary

Pattern hair loss, also called androgenetic alopecia (AGA) is considered the most common cause of hair loss in both males and females affecting approximately 85% of males and 50% of females over 50 years of age.


Clinical Trial Description

RF (Radiofrequency) based devices have also been shown to be successful in promoting hair growth, thought to occur through the induction of growth factors in the papillary dermis. Studying the effect of fractional needling radiofrequency in the treatment of female pattern hair loss will pave the way for more treatment options for this common disease. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05409755
Study type Interventional
Source Cairo University
Contact
Status Not yet recruiting
Phase N/A
Start date June 25, 2022
Completion date September 15, 2022

See also
  Status Clinical Trial Phase
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Completed NCT01451021 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Completed NCT01451138 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) Phase 2
Completed NCT03351322 - ENERGI-F701 for Female Hair Loss Treatment Phase 2
Completed NCT01451125 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) Phase 2
Completed NCT01451177 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) Phase 2
Recruiting NCT06333600 - Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss Phase 1/Phase 2
Not yet recruiting NCT05888922 - Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia Phase 3
Completed NCT01669746 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) Phase 2
Completed NCT01451099 - A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Withdrawn NCT04379583 - HairDx Analytical Validation Study
Completed NCT01451190 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) Phase 2
Completed NCT01451047 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) Phase 2
Not yet recruiting NCT05824065 - Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss Phase 3
Not yet recruiting NCT02316418 - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) N/A
Completed NCT01016964 - Treatment of Androgenetic Alopecia in Females, 12 Beam N/A
Completed NCT01451073 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) Phase 2
Completed NCT01451151 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) Phase 2
Completed NCT04898166 - Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
Completed NCT01451112 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) Phase 2